Who are FOLX Health's decision-makers?
FOLX Health's public leadership centers on Liana Douillet Guzman, Clinical leadership, Community platform leadership. Buying decisions vary by category but generally include executive, clinical, operations, product, compliance, security, and finance stakeholders.
- CEO
- Liana Douillet Guzman
- CTO/key exec
- Clinical leadership
- Founded
- 2019
- Employees
- 51-200 reported range
- HQ
- Boston, MA
- Notable
- Private; Series B
- Liana Douillet GuzmanCEOCEO since 2022Leads FOLX's national expansion and whole-person LGBTQIA+ care strategy.
- Clinical leadershipAffirming care cliniciansCurrent care functionFOLX says most providers identify as LGBTQIA+.
- Community platform leadershipSupport groups and educationCurrent functionBuilds events, resources, and peer support.
Who leads FOLX Health?
Liana Douillet Guzman, Clinical leadership, Community platform leadership are the key public leaders in this profile. Their backgrounds indicate where strategy, clinical credibility, operations, product, and commercialization decisions are likely anchored.
Who actually makes buying decisions at FOLX Health?
For clinical, patient, or payer-facing software, buying decisions usually require executive sponsorship plus clinical, compliance, legal, security, finance, and product review. For GTM, workforce, or back-office tools, operations and finance may lead but compliance and security still gate deployment.
How is FOLX Health organized as it scales?
FOLX Health appears organized around product, clinical or healthcare operations, customer growth, compliance, data, and partnerships. Sellers should align outreach to the operational problem they solve instead of starting with only the CEO.
As of June 2026.Sources:FOLX homepageFOLX membership costFOLX Series B
FOLX Health — frequently asked questions
